Treace Medical Concepts Inc (TMCI)
7.94
-0.04
(-0.50%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
+0.01
(+0.13%)
After-Hours: 20:00
Treace Medical Concepts Gross Profit Margin (Quarterly): 80.14% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 80.14% |
| June 30, 2024 | 80.25% |
| March 31, 2024 | 80.19% |
| December 31, 2023 | 81.56% |
| September 30, 2023 | 80.38% |
| June 30, 2023 | 81.71% |
| March 31, 2023 | 80.95% |
| December 31, 2022 | 81.87% |
| September 30, 2022 | 81.58% |
| June 30, 2022 | 82.34% |
| Date | Value |
|---|---|
| March 31, 2022 | 82.34% |
| December 31, 2021 | 83.94% |
| September 30, 2021 | 80.35% |
| June 30, 2021 | 80.90% |
| March 31, 2021 | 82.22% |
| December 31, 2020 | 78.91% |
| September 30, 2020 | 79.59% |
| June 30, 2020 | 73.06% |
| March 31, 2020 | 78.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.06%
Minimum
Jun 2020
83.94%
Maximum
Dec 2021
80.58%
Average
80.90%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 64.02% |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -0.14% |
| Xtant Medical Holdings Inc | 58.37% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.68% |
| Return on Assets | -26.20% |
| Return on Invested Capital | -34.77% |
| Profit Margin (Quarterly) | -34.07% |
| Operating Margin (Quarterly) | -33.57% |
| Return on Net Operating Assets | -49.26% |